Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-3104-2017Class II

JTS External Drive Unit JTS Distal Femoral Extendible Implant Femur is intended for the replacement of...

Stanmore Implants Worldwide, Ltd. / initiated 2017-07-04 / Terminated / root cause: labeling and UDI

Stanmore Implants Worldwide Ltd. began a recall of JTS External Drive Unit JTS Distal Femoral Extendible Implant Femur is intended for the replacement of diseased or deficient bone in the distal femur on . FDA classified it as Class II and gives the reason as "Three (3) complaints were identified in which the potential for utilization of the JTS Grower Drive in the incorrect orientation in relation to the limb entry point of the device, together with the potential to select...". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-3104-2017
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Stanmore Implants Worldwide, Ltd.
Product
JTS External Drive Unit JTS Distal Femoral Extendible Implant Femur is intended for the replacement of diseased or deficient bone in the distal femur.
Product code
KRO Prosthesis, Knee, Femorotibial, Constrained, Cemented, Metal/Polymer
Reason for recall
Three (3) complaints were identified in which the potential for utilization of the JTS Grower Drive in the incorrect orientation in relation to the limb entry point of the device, together with the potential to select incorrect settings for the extension procedure. As a result, the prostheses in such cases failed to extend as intended.
Root cause tag
labeling and UDI
FDA root cause
Labeling design
Action
Stanmore Implants sent an Urgent Field Safety Notice dated July 4, 2017, notifying customers of the recall. Additionally, the recalling firm requests that consignees immediately check their inventory for recalled product, quarantine any product on hand, inform SIW of any product on hand, complete the attached response form, and return the response for and affected product to the firm. It is requested that consignees distribute the notice internally to all affected parties and that they contact their local Stanmore representative to request training. If any adverse events are associated with this device, the firm asks that it be reported to them. For further questions, please call (972) 501-1402.
Quantity in commerce
15 units
Distribution
US Distribution to the states of : CA, FL, GA, KS, MI, NJ, OH, PA, SC, and TX.
Product codes and lots
Product Code MLE3; Serial No. 907-103, 907-104, 907-119, 907-123, 907-125, 907-126, 907-127, 907-028, 907-237, 907-240, 907-500, 907-501, 907-502, 907-503, 907-504.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-3104-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-3104-2017Class IITerminatedVoluntary: Firm initiated